IDEAYA Biosciences, Inc. (IDYA)
36.83
-0.55
(-1.47%)
USD |
NASDAQ |
Jan 12, 16:00
36.83
0.00 (0.00%)
After-Hours: 18:40
IDEAYA Biosciences Research and Development Expense (Quarterly): 82.99M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Pfizer Inc. | 2.492B |
| Regeneron Pharmaceuticals, Inc. | 1.338B |
| Sarepta Therapeutics, Inc. | 218.89M |
| Rezolute, Inc. | 13.15M |
| GT Biopharma, Inc. | 0.634M |